UK antihistamines
This article was originally published in The Tan Sheet
Executive Summary
Medicines Control Agency proposes lifting pharmacy pack size restrictions for loratadine (Schering-Plough's Claritin) and cetirizine (Zyrtec, marketed by UCB Pharma in UK) in an Aug. 24 "consultation letter" amendment. Antihistamines currently are sold in packs containing "not more than seven tablets." Responses to MCA's June 15 proposal to reclassify the two drugs to "general sales list," which permits distribution in non-pharmacy outlets, suggested the additional change (1"The Tan Sheet" July 2, p. 3). MCA will accept comments through Oct. 18
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning